Sixteen patients with HNF@A diabetes ( @ women ; mean age @ years -LSB- range @-@ years -RSB- ; BMI @ @ kg/m ( @ ) -LSB- mean SEM -RSB- ; fasting plasma glucose -LSB- FPG -RSB- @ @ mmol/L ; HbA@c @ @ % -LSB- @ @ mmol/mol -RSB- ) received @ weeks of treatment with a GLP-@RA ( liraglutide ) and placebo ( tablets ) , as well as a sulfonylurea ( glimepiride ) and placebo ( injections ) , in randomized order , in a double-blind , crossover trial .